Skip to main content

Advertisement

SpringerLink
Log in

Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Various factors influence quality of life (QoL) in acromegaly. Whether disease control and treatment approach are related to QoL is still a matter of debate. The aim of the present study was to evaluate QoL in patients with acromegaly using the disease-specific Acromegaly Quality of Life Questionnaire in respect to disease activity, treatment modalities, and other factors. We studied 212 patients with acromegaly in a cross-sectional manner over a 6-year period in a single tertiary center. As a second step, seventy of the patients who were with active disease at baseline were followed up prospectively and 45 of them were in remission at re-evaluation. In regard to the cross-sectional group, active acromegaly independently predicted worse appearance scores. Prior radiotherapy and older age were independent negative predictors of all scales. Female gender negatively predicted all scales except the appearance domain. Longer duration of remission predicted worse personal relations scores in biochemically controlled patients. The use of somatostatin analog (SSA) was associated with worse personal relations scores, while higher IGF-1 index predicted worse appearance scores in patients with active acromegaly. In the prospective group, achievement of remission independently predicted improvement of the total scale. Lower corresponding baseline scores predicted improvement of the total, physical, and appearance scales, while the absence of hypopituitarism independently predicted improvement of the appearance scale. The use of SSA was associated with improvement of the total and appearance scores. In conclusion, QoL is a multifactorial issue that needs an individualized approach for detection and management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. O.M. Dekkers, N.R. Biermasz, A.M. Pereira, J.A. Romijn, J.P. Vandenbroucke, Mortality in acromegaly: a metaanalysis. J. Clin. Endocrinol. Metab. 93(1), 61–67 (2008). doi:10.1210/jc.2007-1191

    Article  CAS  PubMed  Google Scholar 

  2. A. Santos, E. Resmini, M.A. Martinez, C. Marti, J. Ybarra, S.M. Webb, Quality of life in patients with pituitary tumors. Curr. Opin. Endocrinol. Diabetes Obes. 16(4), 299–303 (2009). doi:10.1097/MED.0b013e32832cdec9

    Article  PubMed  Google Scholar 

  3. S.M. Webb, X. Badia, N.L. Surinach, Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur. J. Endocrinol. 155(2), 269–277 (2006). doi:10.1530/eje.1.02214

    Article  CAS  PubMed  Google Scholar 

  4. N.R. Biermasz, S.W. van Thiel, A.M. Pereira, H.C. Hoftijzer, A.M. van Hemert, J.W. Smit, J.A. Romijn, F. Roelfsema, Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J. Clin. Endocrinol. Metab. 89(11), 5369–5376 (2004). doi:10.1210/jc.2004-0669

    Article  CAS  PubMed  Google Scholar 

  5. S.V. Rowles, L. Prieto, X. Badia, S.M. Shalet, S.M. Webb, P.J. Trainer, Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J. Clin. Endocrinol. Metab. 90(6), 3337–3341 (2005). doi:10.1210/jc.2004-1565

    Article  CAS  PubMed  Google Scholar 

  6. S.C. Hua, Y.H. Yan, T.C. Chang, Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly. Eur. J. Endocrinol. 155(6), 831–837 (2006). doi:10.1530/eje.1.02292

    Article  CAS  PubMed  Google Scholar 

  7. G. T’Sjoen, M. Bex, D. Maiter, B. Velkeniers, R. Abs, Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly. Eur. J. Endocrinol. 157(4), 411–417 (2007). doi:10.1530/EJE-07-0356

    Article  PubMed  Google Scholar 

  8. R. Trepp, R. Everts, C. Stettler, S. Fischli, S. Allemann, S.M. Webb, E.R. Christ, Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life questionnaire (AcroQoL). Clin. Endocrinol. (Oxf) 63(1), 103–110 (2005). doi:10.1111/j.1365-2265.2005.02307.x

    Article  Google Scholar 

  9. M.P. Matta, E. Couture, L. Cazals, D. Vezzosi, A. Bennet, P. Caron, Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance. Eur. J. Endocrinol. 158(3), 305–310 (2008). doi:10.1530/EJE-07-0697

    Article  CAS  PubMed  Google Scholar 

  10. C. Sardella, M. Lombardi, G. Rossi, C. Cosci, S. Brogioni, I. Scattina, S.M. Webb, M. Gasperi, E. Martino, F. Bogazzi, Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study. J. Endocrinol. Invest. 33(1), 20–25 (2010)

    Article  CAS  PubMed  Google Scholar 

  11. H. Kepicoglu, E. Hatipoglu, I. Bulut, E. Darici, N. Hizli, P. Kadioglu, Impact of treatment satisfaction on quality of life of patients with acromegaly. Pituitary (2013). doi:10.1007/s11102-013-0544-7

    Google Scholar 

  12. N.R. Biermasz, A.M. Pereira, J.W. Smit, J.A. Romijn, F. Roelfsema, Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J. Clin. Endocrinol. Metab. 90(5), 2731–2739 (2005). doi:10.1210/jc.2004-2297

    Article  CAS  PubMed  Google Scholar 

  13. S.J. Neggers, M.O. van Aken, W.W. de Herder, R.A. Feelders, J.A. Janssen, X. Badia, S.M. Webb, A.J. van der Lely, Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant. J. Clin. Endocrinol. Metab. 93(10), 3853–3859 (2008). doi:10.1210/jc.2008-0669

    Article  CAS  PubMed  Google Scholar 

  14. M.R. Postma, R.T. Netea-Maier, G. van den Berg, J. Homan, W.J. Sluiter, M.A. Wagenmakers, A.C. van den Bergh, B.H. Wolffenbuttel, A.R. Hermus, A.P. van Beek, Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly. Eur. J. Endocrinol. 166(4), 585–592 (2012). doi:10.1530/EJE-11-0853

    Article  CAS  PubMed  Google Scholar 

  15. R. Mangupli, P. Camperos, S.M. Webb, Biochemical and quality of life responses to octreotide-LAR in acromegaly. Pituitary (2013). doi:10.1007/s11102-013-0533-x

    PubMed Central  Google Scholar 

  16. A.A. van der Klaauw, N.R. Biermasz, H.C. Hoftijzer, A.M. Pereira, J.A. Romijn, Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly. Clin. Endocrinol. (Oxf) 69(1), 123–128 (2008). doi:10.1111/j.1365-2265.2007.03169.x

    Article  Google Scholar 

  17. E. Hatipoglu, N. Topsakal, O.E. Atilgan, N. Alcalar, A.F. Camliguney, M. Niyazoglu, H.B. Cotuk, P. Kadioglu, Impact of exercise on quality of life and body-self perception of patients with acromegaly. Pituitary 17(1), 38–43 (2014). doi:10.1007/s11102-013-0463-7

    Article  PubMed  Google Scholar 

  18. S.M. Webb, L. Prieto, X. Badia, M. Albareda, M. Catala, S. Gaztambide, T. Lucas, C. Paramo, A. Pico, A. Lucas, I. Halperin, G. Obiols, R. Astorga, Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin. Endocrinol. (Oxf) 57(2), 251–258 (2002)

    Article  CAS  Google Scholar 

  19. A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. Von Werder, S. Melmed, Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85(2), 526–529 (2000)

    CAS  PubMed  Google Scholar 

  20. M.C. Sheppard, Growth hormone assay standardization: an important clinical advance. Clin. Endocrinol. (Oxf) 66(2), 157–161 (2007). doi:10.1111/j.1365-2265.2007.02703.x

    Article  CAS  Google Scholar 

  21. A.N. Paisley, S.V. Rowles, M.E. Roberts, S.M. Webb, X. Badia, L. Prieto, S.M. Shalet, P.J. Trainer, Treatment of acromegaly improves quality of life, measured by AcroQol. Clin. Endocrinol. (Oxf) 67(3), 358–362 (2007). doi:10.1111/j.1365-2265.2007.02891.x

    Article  CAS  Google Scholar 

  22. P. Anagnostis, Z.A. Efstathiadou, M. Charizopoulou, D. Selalmatzidou, E. Karathanasi, M. Poulasouchidou, M. Kita, Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases? Endocrine (2014). doi:10.1007/s12020-014-0166-5

    PubMed  Google Scholar 

  23. M.J. Wassenaar, N.R. Biermasz, M. Kloppenburg, A.A. van der Klaauw, J. Tiemensma, J.W. Smit, A.M. Pereira, F. Roelfsema, H.M. Kroon, J.A. Romijn, Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients. Growth Horm IGF Res. 20(3), 226–233 (2010). doi:10.1016/j.ghir.2010.02.003

    Article  CAS  PubMed  Google Scholar 

  24. B.J. Spiegler, E. Bouffet, M.L. Greenberg, J.T. Rutka, D.J. Mabbott, Change in neurocognitive functioning after treatment with cranial radiation in childhood. J. Clin. Oncol. 22(4), 706–713 (2004). doi:10.1200/JCO.2004.05.186

    Article  PubMed  Google Scholar 

  25. A. Miller, H. Doll, J. David, J. Wass, Impact of musculoskeletal disease on quality of life in long-standing acromegaly. Eur. J. Endocrinol. 158(5), 587–593 (2008). doi:10.1530/EJE-07-0838

    Article  CAS  PubMed  Google Scholar 

  26. P.J. Jenkins, P. Bates, M.N. Carson, P.M. Stewart, J.A. Wass, Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J. Clin. Endocrinol. Metab. 91(4), 1239–1245 (2006). doi:10.1210/jc.2005-1616

    Article  CAS  PubMed  Google Scholar 

  27. S.J. Neggers, J.J. Kopchick, J.O. Jorgensen, A.J. van der Lely, Hypothesis: extra-hepatic acromegaly: a new paradigm? Eur. J. Endocrinol. 164(1), 11–16 (2011). doi:10.1530/EJE-10-0969

    Article  CAS  PubMed  Google Scholar 

  28. T. Psaras, J. Honegger, B. Gallwitz, M. Milian, Are there gender-specific differences concerning quality of life in treated acromegalic patients? Exp. Clin. Endocrinol. Diabetes 119(5), 300–305 (2011). doi:10.1055/s-0030-1267912

    Article  CAS  PubMed  Google Scholar 

  29. A.P. Arnold, Promoting the understanding of sex differences to enhance equity and excellence in biomedical science. Biol. Sex Differ. 1(1), 1 (2010). doi:10.1186/2042-6410-1-1

    Article  PubMed Central  PubMed  Google Scholar 

  30. T. Wexler, L. Gunnell, Z. Omer, K. Kuhlthau, C. Beauregard, G. Graham, A.L. Utz, B. Biller, L. Nachtigall, J. Loeffler, B. Swearingen, A. Klibanski, K.K. Miller, Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly. J. Clin. Endocrinol. Metab. 94(7), 2471–2477 (2009). doi:10.1210/jc.2008-2671

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This work has been supported by the National Science Fund, Ministry of Education, Youth and Science, Grant No. DO02-356/31.12.2008.

Conflict of interest

The authors declare that there is no conflict of interest that would prejudice the impartiality of the reported scientific work.

Author information

Authors and Affiliations

  1. Clinical Center of Endocrinology and Gerontology, Medical University – Sofia, Zdrave 2 str., 1431, Sofia, Bulgaria

    Silvia Vandeva, Maria Yaneva, Emil Natchev, Atanaska Elenkova & Sabina Zacharieva

  2. New Bulgarian University, Sofia, Bulgaria

    Krasimir Kalinov

Authors
  1. Silvia Vandeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Yaneva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emil Natchev
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Atanaska Elenkova
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Krasimir Kalinov
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sabina Zacharieva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Silvia Vandeva.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vandeva, S., Yaneva, M., Natchev, E. et al. Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire. Endocrine 49, 774–782 (2015). https://doi.org/10.1007/s12020-014-0521-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-014-0521-6

Keywords

Search

Navigation